Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
349 Leser
Artikel bewerten:
(1)

SERSTECH AB: Serstech launches several new products and enters the pharmaceutical market

Serstech today launches new versions of the Serstech 100 Indicator and the ChemDash software, both of which target the pharmaceutical and life-science market. The instrument and software are compliant with FDA (US Food and Drug Administration) regulatory framework that most pharmaceutical producers around the world adhere to.

The market for hand-held Raman instruments is estimated to be valued at 30 MEUR annually and Serstech already has 30 sales partners around the world addressing this market. Using Serstech's hardware and software to verify incoming goods, without opening the containers, will allow pharmaceutical producers to improve their efficiency and reduce cost.

"The FDA compliance is an absolute requirement for sales to this segment and the feedback we have from our partners and their customers is very promising", says Stefan Sandor, Serstech CEO.

Today, Serstech also launches its Heroin ID Kit, which is targeted at the security industry and is sold as an accessory to the Serstech 100 Indicator. During the summer, Serstech has applied for a patent for the solution, which uses SERS technology (Surface Enhanced Raman Spectroscopy) to greatly amplify the Raman signal in substances with a weak signal or high noise, such as heroin. The Heroin ID Kit solves a problem inherent in the underlying Raman technology and allows for quick and easy identification of heroin street samples.

"This is our second patent application in less than a year and we are confident that our Heroin ID Kit is one of the best in the market", says Johan Diedrichs, Serstech VP R&D.

For further information, please contact:

Stefan Sandor,
CEO, Serstech AB
tel: +46 739 606067
email: ss@serstech.com

Thomas Pileby,
Chairman of the Board, Serstech AB
tel: +46 702 072643
email: tp@serstech.com
Company website: www.serstech.com

The information was submitted for publication, through the agency of the contact person set out above at 09:15 CET on September 2, 2019.

Certified advisor to Serstech is Västra Hamnen Corporate Finance AB, phone: 040-20 02 50, e-mail: ca@vhcorp.se

About Serstech
Serstech delivers solutions for chemical identifications and has customers across the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech's solution. Serstech is traded at Nasdaq First North and more information about the company can be found at www.serstech.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.